Notation to File

CUPID

Jinfiniti Precision Medicine, Inc.

Notation to File

NOTE TO THE FILE


SERIAL NUMBER:            88480746

DATE:                                09/18/2019

NAME:                               mwinter

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                               Left message with
    X   email                               Attorney/Applicant

     Requested Law Library search       X   Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

     OTHER:

Hello Melissa!

 

I hope that you are doing well today.   Thank you very much for your email yesterday, and yes, the proposed amendments are acceptable. 

 

I also received the Notices regarding CAMID and TumorAmp as well.  I will address them as instructed in the Notices.  I appreciate your thorough response and valuable guidance. 

 

Thanks again, and I look forward to next steps.

 

Have a wonderful day!

 

All the best,

 

Bernard H. Coleman, Esq.
The Coleman Law Firm, LLC
3350 Riverwood Parkway
Suite 1900
Atlanta, GA 30339
(o) 404-419-6571
(c) 404-964-4835

LinkedIn: http://www.linkedin.com/in/bernardcoleman/

Website: http://tclfirm.com/

 

 

NOTICES: This message, including attachments, is confidential and may contain information protected by the attorney-client privilege or work product doctrine. If you are not the addressee, any disclosure, copying, distribution, or use of the contents of this message are prohibited. If you have received this email in error, please destroy it and notify me immediately. Any tax advice contained in this message is not intended or written to be used, and cannot be used, for the purpose of (1) avoiding penalties under the internal revenue code or (2) promoting, marketing, or recommending to others any tax-related matter(s) addressed here. not the addressee, any disclosure, copying, distribution, or use of the contents of this message are prohibited. If you have received this email in error, please destroy it and notify me immediately. Any tax advice contained in this message is not intended or written to be used, and cannot be used, for the purpose of (1) avoiding penalties under the internal revenue code or (2) promoting, marketing, or recommending to others any tax-related matter(s) addressed here.

 

 


From: Winter, Melissa <Melissa.Winter@USPTO.GOV>
Sent: Tuesday, September 17, 2019 11:05:43 AM
To: Bernard H. Coleman, Esq. <bcoleman@tclfirm.com>
Subject: Trademark Application SNs 88479178 (SPOTTUMOR) and 88480746 (CUPID)

 

Dear Mr. Coleman,

 

Good morning.  I am the trademark examining attorney reviewing several of Jinfiniti’s applications.  Before I can approve the following applications for publication, there are some amendments that are necessary.  Please see below. 

 

·         SN 88479178, SPOTTUMOR

 

In this application, the identification of services is indefinite and must be clarified because the nature of the services is uncertain. I propose the following, if accurate (proposed amendments in bold):

 

Class 44: providing cancer screening services;  medical analysis services for early cancer diagnosis and early detection of cancer recurrence; medical testing for treatment purposes, namely, therapeutic monitoring of cancer treatments

 

·         SN 88480746, CUPID

 

In this application, the we just need to clarify the identification a bit to ensure proper classification.  For classification in Class 44, the services must be for medical purposes.  If the services are for research purposes, they are classified in Class 42.  I propose the following in Class 44, if accurate (proposed amendment in bold):

 

Class 44: Genetic and genomic testing for medical purposes, namely, for cancer diagnosis and prognosis

 

If the above amendments are acceptable, I can enter them via Examiner’s Amendments and then I should be able to approve the applications for publication.  I would appreciate a response as soon as possible, but not later than the close of business on Thursday, September 19. 

 

If you have any questions, please feel free to contact me.

 

Sincerely,

 

 

/Melissa S. Winter/

Trademark Examining Attorney

Law Office 122

United States Patent and Trademark Office

PH: 571-272-7913

Melissa.winter@uspto.gov

 

Please note that all relevant e-mail communications will be placed in the official application record. Although the trademark examining attorney may provide additional explanation pertaining to the application, the trademark examining attorney may not provide legal advice or statements about applicant’s rights. See TMEP §§705.02, 709.06.

 

 

         Sent to TICRS as Serial Number: 88479178

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed